BALAXI PHARMACEUTICALS LIMITED (BALAXI) — FY26 Annual Report | 10 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Corrigendum updates AGM voting cut-off date to August 17, 2026
🔄 What Changed
Cut-off date for voting eligibility corrected from August 14 to August 17, 2026
💡 Investor Takeaway
Shareholders must verify the updated voting eligibility date to ensure participation in the AGM.

BALAXI PHARMACEUTICALS LIMITED issued a corrigendum correcting the cut-off date for voting eligibility in its 83rd AGM from August 14 to August 17, 2026, as published in the August 10, 2026 filing. The correction applies to remote e-voting and AGM participation, with no changes to other notice terms. Shareholders are directed to access the updated notice via the company website or email links.

📄 View Original Announcement (PDF)

About BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Healthcare · Pharmaceuticals · Listed on NSE

ROE: 1.1% ROCE: 3.6%

View full BALAXI stock details →

📡 Get AI alerts when BALAXI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BALAXI — Free

📊 More BALAXI filings

See all BALAXI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BALAXI files new disclosures

Track BALAXI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BALAXI — Free

Free account · 2 AI queries/day